H. B. Fuller/$FUL
1D1W1MYTD1Y5YMAX
Capital at risk
About H. B. Fuller
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
- Ticker
- $FUL
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 7,100
- Headquarters
- Saint Paul, United States
- Website
- www.hbfuller.com
H. B. Fuller Metrics
BasicAdvanced
$2.7B
14.65
$3.37
0.96
$0.96
1.98%
Price and volume
Market cap
$2.7B
Beta
0.96
52-week high
$68.63
52-week low
$48.60
Average daily volume
624K
Dividend rate
$0.96
Financial strength
Current ratio
1.796
Quick ratio
0.946
Long term debt to equity
1.063
Total debt to equity
1.063
Dividend payout ratio (TTM)
27.66%
Interest coverage (TTM)
3.88%
Profitability
EBITDA (TTM)
590.521
Gross margin (TTM)
32.25%
Net profit margin (TTM)
5.29%
Operating margin (TTM)
11.60%
Effective tax rate (TTM)
24.86%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
4.86%
Return on equity (TTM)
9.39%
Valuation
Price to earnings (TTM)
14.654
Price to revenue (TTM)
0.768
Price to book
1.28
Price to tangible book (TTM)
-7.04
Price to free cash flow (TTM)
19.14
Free cash flow yield (TTM)
5.22%
Free cash flow per share (TTM)
2.581
Dividend yield (TTM)
1.94%
Forward dividend yield
1.98%
Growth
Revenue change (TTM)
-0.57%
Earnings per share change (TTM)
83.37%
3-year revenue growth (CAGR)
-0.92%
10-year revenue growth (CAGR)
5.37%
3-year earnings per share growth (CAGR)
6.05%
10-year earnings per share growth (CAGR)
5.20%
3-year dividend per share growth (CAGR)
7.02%
10-year dividend per share growth (CAGR)
6.01%
What the Analysts think about H. B. Fuller
Analyst ratings (Buy, Hold, Sell) for H. B. Fuller stock.
Analyst projections of the future price of H. B. Fuller stock.
Bulls say / Bears say
H.B. Fuller’s Q2 2026 results topped analyst expectations with adjusted EPS of $1.41 (versus $1.38 consensus), net revenue of $950 million (up 5.8% y/y), and adjusted EBITDA of $181 million (up 9% y/y), enabling management to raise full-year adjusted EBITDA guidance to $650 million–$675 million (Investing.com).
On August 12, 2026, shareholders of Advanced Medical Solutions approved H.B. Fuller’s recommended cash acquisition, which is expected to close by year-end and deliver approximately $55 million in run-rate synergies to strengthen its medical adhesives segment (H.B. Fuller Press Release).
Adjusted gross margin expanded 170 basis points y/y to 31.3% in Q2 2026, driven by targeted pricing actions, restructuring savings, and the impact of acquisitions under the company’s Project ONE operational improvement initiative (H.B. Fuller Financials).
Net debt remained elevated at $1.958 billion at the end of Q2 2026, reflecting significant leverage from the Royal Adhesives acquisition and constraining financial flexibility amid uncertain refinancing conditions (MarketScreener).
H.B. Fuller’s shares plunged 8.2% in after-hours trading following its Q2 beat, as investors weighed the incremental debt burden and integration risks from the pending AMS acquisition (Investing.com).
Underlying sales volume declined 0.4% year-on-year in Q2 2026, indicating persistent demand weaknesses that were only offset by 3.0% pricing and 3.1% currency translation gains (Form 10-Q).
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2026.
H. B. Fuller Financial Performance
Revenues and expenses
H. B. Fuller Earnings Performance
Company profitability
Upcoming events
No upcoming events
H. B. Fuller News
AllArticlesVideos
Funds containing H. B. Fuller
AllUSDGBPEUR
Fund name | Fund size | $FUL weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.16% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.16% |
SPDR S&P US Dividend Aristocrats€SPYD | €3.3B | 0.12% |
SPDR S&P US Dividend Aristocrats£USDV | £2.8B | 0.12% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.